Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties.
From 1990 to 2019, Norway reduced inequality in disease burden; however, an examination at a more granular level shows inequalities still exist.
We measured life expectancy at birth, by sex and year, for subgroups of people reporting Hispanic, non-Hispanic Black, or non-Hispanic White race/ethnicity.
As per the latest estimates of antimicrobial resistance (AMR) on a global level, at least 1.27 million deaths per year are directly attributable to AMR.
We used advances in meta-regression methods and estimates of vaccine efficacy by location to estimate incremental cost-effectiveness ratios (ICERs) for rotavirus vaccination in 195 countries.
We estimated the global, regional, and national prevalence of hepatitis B virus (HBV), as well as mortality and disability-adjusted life-years (DALYs) due to HBV, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
This analysis estimated life expectancy for five racial–ethnic groups, in 3,110 US counties over 20 years, to describe spatial–temporal variations in life expectancy and disparities between racial–ethnic groups.
New study offers the first comprehensive, county-level life expectancy estimates in the US and highlights important differences among racial and ethnic groups.
This paper samples across a range of potential variant-level characteristics to provide global forecasts of infections, hospitalisations, and deaths in the face of high (but waning) levels of past immunity, and evaluates a range of interventions that may diminish the impact of future waves.
The objective of this study is to examine progress on implementing the Global Strategy by updating previous analyses that estimated and examined official development assistance targeted towards human resources for health.
Dr. Tomislav Meštrović, IHME and the University North (Croatia) discusses antimicrobial resistance.
We identify the pattern of garbage-coded deaths in the world and present the methods used to determine their redistribution to generate more plausible cause of death assignments.
In this independent prospective evaluation, we used both quantitative and qualitative data to assess the potential impact of the Brazil HealthRise programs on improving clinical and health outcomes for hypertension and diabetes patients in Teófilo Otoni and Vitoria da Conquista. We hypothesized that participation in the Brazil HealthRise program could lead to reduced biomarker readings and increase the proportion of individuals meeting treatment targets for both conditions.
More than 43 million additional health workers are needed to meet targets for universal health coverage around the world, according to a new peer-reviewed study.
We aimed to use comparable and standardised data sources to estimate human resources for health (HRH) densities globally, and to examine the relationship between a subset of HRH cadres and UHC effective coverage performance.
Our analysis presents the first ever estimates of entire distributions of stunting, wasting, and underweight for each of 204 countries and territories from 1990 to 2020 for children less than 5 years old by age group and sex.
The trends in vaccine confidence and resistance have implications for updating the social amplification of risk framework (SARF); in turn, SARF has practical implications for guiding efforts to alleviate vaccine hesitancy and to mitigate harms from intentional and unintentional vaccine scares.
We aimed to estimate the health outcomes and net cost of implementing postexposure prophylaxis (PEP) with monoclonal antibodies (mAbs) against household exposure to COVID-19.
Sasha Aravkin, Adjunct Associate Professor and Director of Mathematical Sciences, and Peng Zheng, Assistant Professor, Department of Health Metrics Sciences discuss methodology.
In this study, we aimed to provide a novel approach to estimating past SARS-CoV-2 infections, combining data from reported cases, reported deaths, excess deaths attributable to COVID-19, hospitalizations, and seroprevalence surveys
In this study, we conducted a cost-effectiveness analysis of a Vitamin A Supplementation scale-up in Nigeria, Kenya, and Burkina Faso.
We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades.
Despite severe international sanctions, the Iranian health care system has made significant achievements in controlling the burden of infectious diseases, but it faces health challenges and threats from non-communicable diseases (NCDs), including cardiovascular disease and diabetes, according to a systematic analysis published in The Lancet.
In this systematic analysis, we present the national and subnational estimates of the burden of disease in Iran using the Global Burden of Disease Study 2019.
Prof. Mohsen Naghavi and Prof. Reza Malekzadeh share key insights from the most comprehensive analysis of health in all provinces of Iran.